Mineralys Therapeutics CMO Buys Low, Sells High—Insider Actions Raise Questions About Short‑Term Price Momentum and Long‑Term Confidence
Mineralys Therapeutics insider trades reveal CMO confidence amid heavy exec selling – understand the impact on stock value, liquidity, and future outlook.
3 minutes to read
